On aspirin treatment but not baseline thromboxane B2 levels predict adverse outcomes in patients with acute coronary syndromes


Eiji Matsuura, Collaborative Research Center for Okayama Medical Innovation Center (OMIC) and Department of Cell Chemistry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan.
Tel.: +81 86 235 7402; fax: +81 86 235 7404.
E-mail: eijimatu@md.okayama-u.ac.jp

No abstract is available for this article.